基因和免疫向治疗组合使用双匹配生物标志物用于患者选择
Daisuke Nishizaki1, Razelle Kurzrock2,3, Jacob J Adashek4
1Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA. dnishizaki@health.ucsd.edu.
NPJ precision oncology
|July 24, 2025
概括
使用向药物和免疫检查点抑制剂 (ICI) 的生物标志物匹配组合疗法在晚期癌症中显示出有前途,即使经过多次治疗. 对双重匹配疗法的进一步研究是有必要的.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 基因向疗法和免疫检查点抑制剂 (ICI) 的组合用于晚期癌症.
- 患者选择这些双重疗法往往缺乏对两种治疗类型的综合生物标志物匹配.
研究的目的:
- 评估使用生物标志物匹配的向药物和ICI治疗晚期癌症患者的结果.
- 评估结合针对性治疗和ICI双重生物标志物选择的临床试验的流行率.
主要方法:
- 对接受双重治疗的17名晚期癌症患者的回顾性分析,与基因组和免疫生物标志物相匹配.
- 数据库搜索以确定使用双生物标志物为向治疗和ICI的基于选择的临床试验.
主要成果:
- 在晚期癌症患者中,疾病控制率为53%,包括那些有≥3次先前治疗的患者.
- 无进展生存 (PFS) 的中位数为6.1个月,总生存 (OS) 为9.7个月.
- 三名患者 (18%) 获得了长时间的PFS和OS与特定的癌症类型;只有1.3%的试验使用双生物标志物匹配.
结论:
- 双生物标志物匹配组合疗法在晚期癌症中表现出潜力,即使在严重预先治疗的患者中也是如此.
- 进一步的研究和双匹配治疗策略的开发得到了这些发现的支持.
- 目前的试验数量有限,凸显了基于生物标志物的双重治疗研究中的差距.
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662